- Home
- ICCM vs ECOR Comparison
ICCM vs ECOR Comparison
Compare ICCM & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCM
- ECOR
- Stock Information
- Founded
- ICCM 2006
- ECOR 2005
- Country
- ICCM Israel
- ECOR United States
- Employees
- ICCM N/A
- ECOR N/A
- Industry
- ICCM
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- ICCM
- ECOR Health Care
- Exchange
- ICCM Nasdaq
- ECOR Nasdaq
- Market Cap
- ICCM 70.1M
- ECOR 40.1M
- IPO Year
- ICCM N/A
- ECOR 2018
- Fundamental
- Price
- ICCM $1.03
- ECOR $5.19
- Analyst Decision
- ICCM Strong Buy
- ECOR Strong Buy
- Analyst Count
- ICCM 1
- ECOR 2
- Target Price
- ICCM $2.50
- ECOR $25.50
- AVG Volume (30 Days)
- ICCM 196.6K
- ECOR 122.7K
- Earning Date
- ICCM 05-27-2025
- ECOR 05-07-2025
- Dividend Yield
- ICCM N/A
- ECOR N/A
- EPS Growth
- ICCM N/A
- ECOR N/A
- EPS
- ICCM N/A
- ECOR N/A
- Revenue
- ICCM $3,291,000.00
- ECOR $25,182,000.00
- Revenue This Year
- ICCM $97.02
- ECOR $32.20
- Revenue Next Year
- ICCM $212.86
- ECOR $46.27
- P/E Ratio
- ICCM N/A
- ECOR N/A
- Revenue Growth
- ICCM 1.92
- ECOR 57.09
- 52 Week Low
- ICCM $0.48
- ECOR $5.02
- 52 Week High
- ICCM $1.66
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- ICCM 37.29
- ECOR 31.29
- Support Level
- ICCM $1.00
- ECOR $6.01
- Resistance Level
- ICCM $1.34
- ECOR $7.14
- Average True Range (ATR)
- ICCM 0.08
- ECOR 0.80
- MACD
- ICCM -0.01
- ECOR 0.07
- Stochastic Oscillator
- ICCM 8.82
- ECOR 3.99
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.